Science
Synthetic cell components reach production following supply chain shortages
A dedicated facility is producing open-access biological kits following component shortages, according to Hacker News.
The short version
- A team established an open-access manufacturing facility in San Francisco between late 2025 and early 2026 to produce synthetic cell components.[Hacker News]
- The initiative responded to restrictive licensing and supply shortages after vendors Roche and Sigma stopped supplying critical tRNA reagents in 2023.[Hacker News]
- The plant has distributed more than 100 Cytosol kits to support projects across roughly 20 laboratories globally.[Hacker News]
Key facts
- The project originated in 2023 under a contract to develop a synthetic cell sensor using fully open and specified components.[Hacker News]
- Commercial suppliers Roche and Sigma halted tRNA supplies in 2023, causing indefinite fulfillment delays.[Hacker News]
- By mid-2025, open protocols, specifications, and materials were completed to manufacture all PURE system components.[Hacker News]
- A manufacturing facility built between late 2025 and early 2026 in San Francisco has supplied over 100 Cytosol kits to roughly 20 laboratories.[Hacker News]
Sources
Outlet counts describe coverage, not independent confirmation. Reports may share a wire service or original source.